002868 Lifecome Biochemistry
- 17.23
- -1.91-9.98%
Lifecome Biochemistry News
Lukang Biochemical (002868.SZ): Net loss of 31.3428 million yuan in the first quarter
Gelonghui, April 30, 丨 Lukang Biochemical (002868.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 160 million yuan, up 60.09% year on year; net profit attributable to shareholders of listed companies was 31.3428 million yuan, an increase in year-on-year losses; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - RMB 32.2093 million; and basic earnings per share - 0.2 yuan.
Benign Growth For Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Underpins Stock's 28% Plummet
The Lifecome Biochemistry Co.,Ltd. (SZSE:002868) share price has fared very poorly over the last month, falling by a substantial 28%. For any long-term shareholders, the last month ends a year to f
Lukang Biochemical (002868.SZ): The natamycin series products produced are mainly used for food preservation and preservation
Gelonghui March 26 | Lukang Biochemical (002868.SZ) said on the investor interactive platform that the natamycin series products produced by the company are mainly used for food preservation and preservation, and can be used in cheese, bread and pastries, braised meat products, fried meat, salad dressing, etc.
Lukang Biochemical (002868.SZ) plans to sell part of its assets located in Pudan Biological Professional Park to Putan Thermal Energy for 67.5 million yuan
Zhitong Finance App News, Lukang Biochemical (002868.SZ) announced that the company intends to sell some equipment fixed assets, building fixed assets and state-owned land use rights located in the Pudan Biological Professional Park in Pucheng County, Fujian Province. The transaction price is 67.5 million yuan (tax included). The details of this transaction are some equipment fixed assets, building-type fixed assets and state-owned land use rights located in Putan Biological Professional Park in Pucheng County, Fujian Province. Among them, there are 5 housing buildings, which are comprehensive housing, temporary storage workshops for sludge dehydration and drying, pharmacies, and hazardous waste
Revenues Not Telling The Story For Lifecome Biochemistry Co.,Ltd. (SZSE:002868) After Shares Rise 30%
Lifecome Biochemistry Co.,Ltd. (SZSE:002868) shareholders are no doubt pleased to see that the share price has bounced 30% in the last month, although it is still struggling to make up recently lost g
Lifecome Biochemistry Co.,Ltd.'s (SZSE:002868) 26% Gain Last Week Benefited Both Private Companies Who Own 43% as Well as Insiders
Key Insights Significant control over Lifecome BiochemistryLtd by private companies implies that the general public has more power to influence management and governance-related decisions 51% of the
Lukang Biochemical (002868.SZ): Pre-loss of 210 million yuan to 230 million yuan in 2023
Gelonghui, January 29丨Lukang Biochemical (002868.SZ) announced the 2023 annual results forecast, with operating income of 51 million yuan to 520 million yuan; net profit loss attributable to shareholders of listed companies of 21 million yuan to 230 million yuan, loss of 121.94 million yuan in the same period last year; net profit loss after deducting non-recurring profit and loss of 225 million yuan to 250 million yuan; loss of 123.21 million yuan for the same period last year; basic earnings loss per share of 1.35 yuan/share — 1.48 yuan/share. During the reporting period, the company's operating income compared to the same period last year
Lifecome Biochemistry Co.,Ltd.'s (SZSE:002868) Shares Climb 31% But Its Business Is Yet to Catch Up
Lifecome Biochemistry Co.,Ltd. (SZSE:002868) shareholders would be excited to see that the share price has had a great month, posting a 31% gain and recovering from prior weakness. But the last mon
Does Lifecome BiochemistryLtd (SZSE:002868) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we thi
Lukang Biochemical (002868.SZ): Some supervisors and executives plan to reduce their holdings by no more than 161,000 shares
Gelonghui, January 12 | Lukang Biochemical (002868.SZ) announced that shareholder Feng Zhenwu directly held 115,725 shares of the company (0.07% of the company's total share capital) to reduce his holdings of the company's shares by no more than 28,931 shares (0.019% of the company's total share capital) through centralized bidding transactions (excluding the period where holdings reduction is prohibited according to relevant laws and regulations) within 3 months after the announcement of the capital reduction plan. Shareholder Lou Lijun directly held 55,282 shares of the company (accounting for 0.04% of the company's total share capital) and traded 15 shares since the date of the announcement of the capital reduction plan
Lukang Biochemical (002868.SZ): Proposed establishment of a wholly-owned subsidiary Lukang Import & Export
Gelonghui November 20 | Lukang Biochemical (002868.SZ) announced that on November 20, 2023, the company held the 35th (interim) meeting of the fourth board of directors to deliberate and pass the “Proposal on the Establishment of Wholly-owned Subsidiaries for Foreign Investment”. Based on strategic planning and future business development needs, the company plans to invest in the establishment of a wholly-owned subsidiary, Lukang Xinneng (Shanghai) Import and Export Co., Ltd. (“Lukang Import and Export” for short, the provisional name, subject to industrial and commercial registration). The company invests in its own capital and other means, with a registered capital of 10 million yuan, and holds 100% of Lukang's shares in import and export.
[Instant Analysis of BT Financial Report] Lukang Biochemical's 2023 Interim Report: Revenue Increased by 59.46%, PV Film Business Boosts Performance Growth
Lukang Biochemical (stock code: 002868) is a high-tech enterprise focusing on R&D, production and sales of veterinary drugs. In the 2023 interim report, the company achieved operating income of 230,041,548.11 yuan, an increase of 59.46% over the previous year. This is mainly due to the company's successful acquisition of Jiangxi Weike New Material Technology Co., Ltd., and invested in the establishment of Lukang (Haining) Adhesive Film Material Co., Ltd. to enter the photovoltaic film industry, forming a development model for the dual main business of “mobile protection products+photovoltaic film products”. As can be seen from the financial data, the company's operating costs increased by 55.92% year-on-year, mainly
Lukang Biochemical (002868SZ) related supervisors and executives reduced their holdings by a total of 53,600 shares
According to the Zhitong Finance App, Lukang Biochemical (002868.SZ) issued an announcement. As of the disclosure date of this announcement, the relevant supervisors and executives Feng Zhenwu, Li Junhui, Huang Hui, and Bao Zhongshou have implemented the holdings reduction plan. The above personnel have now reduced their holdings by a total of 53,600 shares.
Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Surges 10%; Retail Investors Who Own 54% Shares Profited Along With Insiders
Key Insights Significant control over Lifecome BiochemistryLtd by retail investors implies that the general public has more power to influence management and governance-related decisions 46% of the
Is Lifecome BiochemistryLtd (SZSE:002868) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Lifecome Biochemistry Co.,Ltd.'s (SZSE:002868) Last Week's 9.1% Decline Must Have Disappointed Individual Investors Who Have a Significant Stake
Key Insights The considerable ownership by individual investors in Lifecome BiochemistryLtd indicates that they collectively have a greater say in management and business strategy 47% of the busines
Lifecome Biochemistry Resumes Factory Operations
02:08 AM EST, 02/07/2023 (MT Newswires) -- Lifecome Biochemistry (SHE:002868) resumed operations at its Putan veterinary drug factory yesterday. The Chinese biopharmaceutical company temporarily suspe
Swelling Losses Haven't Held Back Gains for Lifecome BiochemistryLtd (SZSE:002868) Shareholders Since They're up 403% Over 1 Year
While stock picking isn't easy, for those willing to persist and learn, it is possible to buy shares in great companies, and generate wonderful returns. When you find (and hold) a big winner, you can
Here's Why Lifecome BiochemistryLtd (SZSE:002868) Can Afford Some Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will
Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Adds CN¥870m in Market Cap and Insiders Have a 60% Stake in That Gain
To get a sense of who is truly in control of Lifecome Biochemistry Co.,Ltd. (SZSE:002868), it is important to understand the ownership structure of the business. And the group that holds the biggest
Analysis
Price Target
No Data
